Niagen Bioscience, Inc. · NASDAQ:NAGE
Niagen Bioscience — ChromaDex — Q3 2018 Earnings Presentation
16 slides from Niagen Bioscience's earnings presentation, Nov 7, 2018
Slide 1: Earnings Conference Call Third Quarter 2018
ShromaDex ‘ChromaDex Earnings Conference Call Third Quarter 2018 ___ Frank Jaksch — Co-Founder [Executive Chairman ~ Rob Fried — ceo Nasdaq: CDXC | November 7, 2018
Slide 2: Disclaimers
Disclaimers ngage nso ac ite ar or ening tr my cra ena ron ets eel sons een st toe se aps gm Sins Sate sn cod epee Sm Sn ese CELSO SRare poser pase elves cl estore Sans sap Sea cg cucu ann tery erg tr ean. dito er uta ret te Da Wee SO Seip heh ipso ng ets wd dS nea eat Se loward sr tomer ierire ae d
Slide 3: Science Continues to Expand
Science Continues to Expand + 26 human studies on nicotinamide riboside in various stages + Two new clinical studies since prior update: *+ University of Maryland, Dr. James Russell (September 2018) *+ Diabetic neuropathy (nerve damage) + Currently no effective disease modifying therapy + Subjects w
Slide 4: Recent Peer-Reviewed Publications
Recent Peer-Reviewed Publications See “Science” section of IR website for link to complete list of studies + Human Molecular Genetics — Vignier ~ “Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A/C gene mutation” ~ August 2018 + Inmou
Slide 5: Dramatic growth of TRU NIAGEN continues
Dramatic growth of TH) TRUNIAGEN continues + TRU NIAGEN sales grew 40% sequentially in Q3 vs Q2, driven by our ecommerce business, as well as a Watsons. We continue to execute our strategy of building TRU NIAGEN into a global brand. + TRU NIAGEN sales showed strong growth in Q3, up 97% Year-Over-Yea
Slide 6: Key Accomplishments
— Key Accomplishments v Launched TRU NIAGEN PRO, highest dose of NR in single capsule Earned certification from NSF International Certified for Sport program v Signed memorandum of understanding for creation of strategic partnership for aging research in Jiangxi Province, China Received regulatory a
Slide 7: Management Team
Management Team Rob Fried ~ Chief Executive Officer Board member since 2035, President, CEO and Director of ideation Acquisition Corp. 2009-2011, Founder and CEO of Feeln 2007-2017 (acquired by Hallmark Cards Inc. in 2012), and Academy Award and Emmy Award winning motion picture producer. Frank Jaks
Slide 8: Financial Highlights
Slide 9: 2016 - 2018 YTD Net Sales Summary
2016 - 2018 YTD Net Sales Summary .
Slide 10: Q3 2018 Net Sales Up 33% to $8.1 Million, Fueled by Growth of TRU NIAGEN
Q3 2018 Net Sales Up 33% to $8.1 Million, Fueled by Growth of TRU NIAGEN® + TRU NIAGEN sales were 84% of total NIAGEN-related sales in Q3 2018 + NIAGEN-related sales in Q3 2018 grew 40% compared to Q3 2017 + NIAGEN-related sales in Q3 2018 were 77% of total sales, compared to 73% in Q3 2017 as 201s
Slide 11: NIAGEN Related Sales — Q3 2017 vs. Q3 2018, +40%
——., NIAGEN Related Sales — Q3 2017 vs. Q3 2018, +40% onto +0 saa
Slide 12: Q3 2018 Profit and Loss
= « 2018 Profit and Loss ed Gunter (rounds, exept 5) Cross Margin Sales and Marketing Research and Development (General and Administrative Total Operating Expenses EPS tom Continuing Operations EPS tom Discontinued Operations 436 ass 1390 e710 2957 009 19) ame HO CHGO DH 5 0):
Slide 13: Q3 2017 Operating Loss vs. Q3 2018 ($M)
EEELEEEEERE Q3 2017 Operating Loss vs. Q3 2018 ($M) 07 2 ee —_ Cir)
Slide 14: Cash Flow
ie Mons (nossa) sep 2018 5192017 nates § gases aewy ‘Sharetated Congasaton aus) Deprecuton nl franca ca ue anton ib Sas & Ober ~ as) ‘awe 4323 ‘ot Copal apni (3s) (08) Proceed tom La Sie + 8068 et Can From Fnac ets Coptal Rave - Secs sue - am Exercise Opcrs zo ey Repurchase cfCommen Sook wou) Prmopa
Slide 15: Outlook
Outlook Continued growth in sales of TRU NIAGEN, driven by: + US. eCommerce + Watsons international business + Launch in certain new international markets Gross profit % of net sales continues to expand Investment spending ahead of revenue growth + Marketing + More focused R&D * Protecting/managing
Slide 16: Contact Info
—— Contact Info